Hillcrest Wealth Advisors NY LLC Sells 15,175 Shares of SPDR S&P Biotech ETF $XBI

Hillcrest Wealth Advisors NY LLC lowered its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 78.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,238 shares of the exchange traded fund’s stock after selling 15,175 shares during the quarter. Hillcrest Wealth Advisors NY LLC’s holdings in SPDR S&P Biotech ETF were worth $425,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. boosted its stake in SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the period. Meitav Investment House Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 2,199.6% during the second quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock worth $33,229,000 after acquiring an additional 383,040 shares during the last quarter. Strs Ohio bought a new position in shares of SPDR S&P Biotech ETF during the first quarter worth $27,801,000. JPMorgan Chase & Co. grew its stake in SPDR S&P Biotech ETF by 2.6% during the second quarter. JPMorgan Chase & Co. now owns 10,638,105 shares of the exchange traded fund’s stock valued at $882,218,000 after acquiring an additional 268,399 shares in the last quarter. Finally, Marshall Wace LLP increased its holdings in SPDR S&P Biotech ETF by 102.3% in the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after acquiring an additional 179,029 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 1.3%

Shares of XBI stock opened at $123.39 on Tuesday. The company’s fifty day simple moving average is $117.34 and its two-hundred day simple moving average is $100.56. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $126.50. The stock has a market cap of $7.49 billion, a P/E ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.